معرفی
Mahima Kapoor is a Lecturer at Monash University, affiliated with Alfred Hospital, focusing on neurology and inflammatory neuropathies. She leads research projects such as the Phase 2/3 clinical trial for Nipocalimab in CIDP and contributes to the Australian CIDP National Registry. Her work addresses treatment responses, biomarkers, and clinical outcomes in neurological disorders.
Research interests include chronic inflammatory demyelinating polyneuropathy (CIDP), neurofilament light chain biomarkers, and the efficacy/safety of immunoglobulin therapies. She collaborates globally through initiatives like the Inflammatory Neuropathy Consortium (INCbase).
Recent publications highlight studies on neurofilament biomarkers in Charcot-Marie-Tooth disease, CIDP treatment prediction models, and IVIg-associated thromboembolic risks. She actively participates in multidisciplinary teams to advance clinical and translational research in neurology.
As a Chief Investigator in major projects, she drives advancements in understanding neuropathy phenotypes and optimizing therapeutic strategies. Her contributions align with global health goals targeting neurological disorder management.
